Lithium (Li+), a mood stabilizer, has profound effects on cultured neurons, offering an opportunity to investigate its cellular biological effects. Here we consider the effect of Li+ and other psychotropic drugs on growth cone morphology and chemotaxis. Li+ inhibits GSK-3 (glycogen synthase kinase-3) at a therapeutically relevant concentration. Treated cells show a number of features that arise due to GSK-3 inhibition, such as altered microtubule dynamics, axonal branching and loss of semaphorin 3A-mediated growth cone collapse. Li+ also causes growth cones to spread; however, a similar effect is seen with two other mood stabilizers, valproic acid and carbamazepine, but without changes in microtubules or axon branching. This common effect of mood stabilizers is mediated by changes in inositol phosphate signalling, not GSK-3 activity. Given the presence of neurogenesis in the adult brain, we speculate that changes in growth cone behaviour could also occur during treatment of mental disorders.
Conference Article| October 26 2004
A molecular cell biology of lithium
- Views Icon Views
- Share Icon Share
- Cite Icon Cite
R. Williams, W.J. Ryves, E.C. Dalton, B. Eickholt, G. Shaltiel, G. Agam, A.J. Harwood; A molecular cell biology of lithium. Biochem Soc Trans 1 November 2004; 32 (5): 799–802. doi: https://doi.org/10.1042/BST0320799
Download citation file: